What are the causes of a prothrombotic state in leptospirosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Prothrombotic State in Leptospirosis

The prothrombotic state in leptospirosis is primarily caused by endothelial damage, inflammatory cytokine storm, and activation of the coagulation cascade, leading to coagulopathy that increases mortality risk.

Pathophysiological Mechanisms

Endothelial Dysfunction

  • Direct endothelial damage: Leptospires and their secreted products can directly injure the vascular endothelium, converting it from an anticoagulant to procoagulant state 1
  • Endothelial activation: Similar to sepsis, leptospirosis causes widespread endothelial activation with increased expression of adhesion molecules and loss of barrier function 2
  • Glycocalyx disruption: The protective endothelial glycocalyx becomes injured, exposing the underlying endothelium and promoting platelet adhesion 2

Inflammatory Response

  • Cytokine storm: Leptospirosis triggers release of pro-inflammatory cytokines (IL-6, TNF-alpha) that activate the coagulation cascade 3
  • Neutrophil activation: Activated neutrophils release neutrophil extracellular traps (NETs) that contribute to thrombosis 2
  • Complement activation: The complement system becomes activated, further promoting inflammation and coagulation 2

Coagulation System Dysregulation

  • Tissue factor upregulation: Both extrinsic and intrinsic coagulation pathways are activated by leptospires 1
  • Contact system activation: Leptospires activate the contact system, leading to bradykinin release and further inflammation 1
  • Procoagulant microvesicles: Infected monocytes shed procoagulant microvesicles that promote thrombin generation 1
  • Reduced anticoagulant proteins: Decreased levels of natural anticoagulants (protein C, antithrombin) are observed in severe leptospirosis 4
  • Fibrinolytic system imbalance: Increased plasminogen activator inhibitor-1 (PAI-1) levels impair fibrinolysis 4

Laboratory Markers

  • Prolonged coagulation times: Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are typically prolonged 4
  • Elevated procoagulant markers: Increased thrombin-antithrombin (TAT) complexes, prothrombin fragment 1+2, and D-dimer levels 4
  • Thrombocytopenia: Consistently observed in leptospirosis and associated with bleeding risk 4, 5

Clinical Implications

Risk Factors for Severe Coagulopathy

  • Disease severity: More pronounced coagulation disorders in patients with severe disease 4
  • Renal dysfunction: Association between renal failure and coagulation abnormalities 6
  • Age: Mortality increases with age, particularly in patients older than 60 years 3

Relationship to Bleeding and Mortality

  • Mortality prediction: PT prolongation is significantly associated with mortality (OR 1.4,95% CI: 1.0-1.8) 4
  • Bleeding risk: Thrombocytopenia (platelets ≤100 × 10^9/L) significantly associated with clinical bleeding (OR 4.6,95% CI: 1.3-16) 4
  • Severe hemorrhage: Imbalance between coagulation and fibrinolysis (TAT/PAP ratio) correlates with severe bleeding 4

Controversies and Pitfalls

DIC vs. Non-DIC Coagulopathy

  • While some studies suggest disseminated intravascular coagulation (DIC) occurs in leptospirosis, others indicate that thrombocytopenia may not be related to classic DIC 5
  • Animal studies show platelet aggregation and phagocytosis by Kupffer cells may contribute to thrombocytopenia without evidence of widespread microthrombi 5

Diagnostic Challenges

  • Leptospirosis may be confused with other febrile illnesses like dengue that also cause coagulopathy 3
  • Failure to consider leptospirosis in patients with undifferentiated fever from endemic regions can lead to diagnostic pitfalls 7

Clinical Management Considerations

  • Early antibiotic therapy: Doxycycline (100 mg orally twice daily for 7 days) is recommended for mild to moderate leptospirosis to prevent progression to severe disease 7
  • Coagulation monitoring: Regular monitoring of platelet counts, PT, aPTT, and fibrinogen levels in severe cases 4
  • Supportive care: Prompt initiation of dialysis for oliguric renal failure can be lifesaving 3
  • Hemorrhage management: Vigilance for pulmonary hemorrhage syndrome, which has >50% fatality rate 3

Understanding these prothrombotic mechanisms is crucial for early recognition and appropriate management of coagulation disorders in leptospirosis, potentially reducing mortality and improving outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Leptospirosis in humans.

Current topics in microbiology and immunology, 2015

Guideline

Leptospirosis and Scrub Typhus Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.